BILL · 2001–02 SESSION
SB 5027: Prescription drugs
Providing for a study of the feasibility of aggregating the purchase and distribution of prescription drugs for certain programs.
Summary
- The Health Care Authority must contract for a study to determine the feasibility of aggregate purchasing of prescription drugs by state and local governments, and for those residents with limited insurance coverage for prescription drugs. The study must separately assess the feasibility of including in the aggregate large private sector prescription drug purchasers.
From the Senate Bill Report (SB 5027), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 8, 2001
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Rosa Franklin (D-29)
- Introduced
- January 8, 2001 in the Senate
- Last action
- January 14, 2002
- Budget
- Makes appropriations · Has a fiscal note
AN ACT Relating to the purchase of prescription drugs by public entities;
Sponsors
Prime sponsor: Rosa Franklin (D-29)
3 co-sponsors (2 Democrats, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health & Long-Term Care.
- Prefiled for introduction.
SB 5027 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5027 (2025–26) Law school loan repayment
- SB 5027 (2023–24) American dream homes
- SB 5027 (2021–22) Television closed captions
- SB 5027 (2019–20) Extreme risk protect. orders
- SB 5027 (2017–18) Distributed generation
- SB 5027 (2015–16) Prescription drug monitoring
- SB 5027 (2013–14) Ballot postage, prepaid
- SB 5027 (2011–12) Motorcycles